Research Fellow in Proteomics and Immunotherapy

About us

The UCL Cancer Institute is one of the world's leading centres for basic and translational cancer research, bringing together more than 400 scientists dedicated to transforming scientific discoveries into better treatments for patients. As part of the CRUK City of London Centre, the Institute collaborates with leading research organisations including UCL, Barts, King's College London, and the Francis Crick Institute to drive innovation in cancer research and therapy development.

About the role

This position is based within a collaborative project between the Maciocia and Surinova laboratories, two internationally recognised groups working at the forefront of immunotherapy and proteomics research. Together, they are developing next-generation CAR-T cell therapies for T-cell lymphoma, an aggressive blood cancer with significant unmet clinical need.

Applications should include a CV and a Cover Letter: In the Cover Letter please provide evidence of the essential and desirable criteria in the Person Specification part of the Job Description. (By including a Cover Letter, you can leave blank the 'Why you have applied for this role' field in the application form, which is limited in the number of characters it will allow.)

The role is offered until 31st January 2030.

About you

You will have a PhD (or be close to completion) in Immunology, Cancer Biology, Cell Biology, Biochemistry, or a related discipline, together with a strong commitment to high-quality translational research. You should possess experience in cell culture, T-cell biology, flow cytometry, molecular biology techniques, and bioinformatic analysis using tools such as R or Python. Ideally, you will also have experience in proteomics, mass spectrometry data analysis, CAR-T cell engineering, or related immunotherapy research. You will be a proactive and independent scientist with excellent organisational, analytical, and problem-solving skills, capable of working effectively across multidisciplinary teams and international collaborations. Strong communication skills, experience presenting scientific findings, and a track record of contributing to publications will enable you to thrive in this role and make a meaningful contribution to advancing treatments for patients with T-cell lymphoma.

What we offer

As well as the exciting opportunities this role presents, we also offer some great benefits some of which are below:

• 41 Days holiday (27 days annual leave 8 bank holiday and 6 closure days)

• Additional 5 days’ annual leave purchase scheme

• Defined benefit career average revalued earnings pension scheme (CARE)
• Cycle to work scheme and season ticket loan

• Immigration loan
• Relocation scheme for certain posts

• On-Site nursery
• On-site gym
• Enhanced maternity, paternity and adoption pay
• Employee assistance programme: Staff Support Service
• Discounted medical insurance

Visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find out more.

Our commitment to Equality, Diversity and Inclusion

As London’s Global University, we know diversity fosters creativity and innovation, and we want our community to represent the diversity of the world’s talent. We are committed to equality of opportunity, to being fair and inclusive, and to being a place where we all belong.

We therefore particularly encourage applications from candidates who are likely to be underrepresented in UCL’s workforce.

These include people from Black, Asian and ethnic minority backgrounds; disabled people; LGBTQI+ people.

Our department holds an Athena SWAN Gold award, in recognition of our commitment and demonstrable impact in advancing gender equality.

Customer advert reference: B02-10938

Advert information